Wealth Enhancement Advisory Services, LLC Renalytix PLC Transaction History
Wealth Enhancement Advisory Services, LLC
- $44.5 Billion
- Q3 2024
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Renalytix PLC stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 63,739 shares of RNLX stock, worth $9,560. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,739
Previous 63,739
-0.0%
Holding current value
$9,560
Previous $14,000
7.14%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RNLX
# of Institutions
29Shares Held
3.91MCall Options Held
13.7KPut Options Held
0-
Pinnacle Associates LTD847KShares$126,9800.0% of portfolio
-
Levin Capital Strategies, L.P. New York, NY555KShares$83,2500.01% of portfolio
-
Tejara Capital LTD London, X0499KShares$74,8650.05% of portfolio
-
Stifel Financial Corp St. Louis, MO489KShares$73,4140.0% of portfolio
-
Ci Private Wealth, LLC Miami, FL336KShares$50,3270.0% of portfolio
About Renalytix plc
- Ticker RNLX
- Exchange OTC
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 37,445,900
- Market Cap $5.62M
- Description
- Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...